TRAF3IP2 and glioblastoma: Silencing TRAF3IP2 suppresses activation of NF-κB and induction of pro-inflammatory mediators, as well as mediators involved in cell cycle and metabolism in U87 glioblastoma cells (Figures 2 and 3); 4.